Effect of treatment with nasal IgA on the incidence of infectious disease in world-class canoeists

International Journal of Sports Medicine

Volumn 17, Issue 3, 1996, Pages 235-238

  Lindberg, K ^b   Berglund, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Athletes; IgA; Immunoglobulin; Infection; Nasopharynx; Treatment

Indexed keywords

IGABULIN; IMMUNOGLOBULIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHLETE; CONTROLLED STUDY; DRUG SALIVA LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INTRANASAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; NOSE SECRETION; SALIVA; TRAINING; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INTRANASAL; ADULT; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; MALE; NASOPHARYNX; PHYSICAL ENDURANCE; RESPIRATORY TRACT INFECTIONS; SALIVA; SALIVARY PROTEINS; SPORTS;

EID: 0029865038     PISSN: 01724622     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-972838     Document Type: Article

References (16)

1. Åkerfeldt S., Geijer S., Holubars E., Fuchs G., Brundin M.: Prophylactic and therpeutic antiviral effect of human gammaglobulin. Biochem Pharmacol 21: 503-509, 1972.
2. Berglund B., Hemmingsson P.: Infectious disease in cross-country skiers: a one-year incidence study. Clin Sports Med 2: 19-23, 1990.
3. Berglund B., Säfström H.: Psychological monitoring and modulation of training load in world-class canoeists. Med Sci Sports Exerc 26 (8): 1-5, 1994.
4. Buthala D. A., Damiano B. S., Eidson E. E.: Studies of Coxsackie A-21 (COE) virus infected volunteers: effect of local therapy with gammaglobulin. Ann NY Acad Sci 173: 794-807, 1970.
5. Cohen S., Tyrell D., Smith A.: Psychological stress and susceptibility to common cold. N Engl J Med 325: 606-612, 1991.
6. Eibl M., Wolf H., Fürnkranz H., Rosenkranz A.: Prevention of necrotising enterocolitis in low-birth-weight infants by IgA-IgGA feeding. N Engl J Med 319: 1-7, 1988.
7. Fruchtman M. H., Maucheri A. A., Wigley F. M., Waldman R. H.: Aerosol administration of human gammaglobulin as prophylaxis against virus challenge. Clin Med 79: 17-20, 1972.
8. Hansson L.-Å-, Björkander J., Oxelius V.-A.: Selective IgA deficiency. In: Chandra R. (ed). Immunodeficiency diseases, Edinburgh: Churchill-Livingstone, 1983, pp 62-83.
9. Hemmingsson P., Hammarström L.: Nasal administration of immunoglobulin as effective prophylaxis against virus challenge. Scand J Infect Dis 25: 783-785, 1993.
10. Keast D., Cameron K., Morton A. R.: Exercise and immune response. Sports Med 5: 248-267, 1988.
11. Lindberg K., Samuelsson A., Rynnel-Dagöö B., Smith E., Hammarström L.: Nasal administration of IgA to individuals with hypogammaglobulinemia. Scand J Infect Dis 25: 395-397, 1993.
12. Mackinnon L. T., Chick T. W., van As A., Tomasi T. B.: The effect of exercise on secretory and natural immunity. Adv Exp Med Biol 216A: 869-876, 1987.
13. Nieman D.: Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc 26: 129-139, 1994.
14. Peters E. M., Bateman E. D.: Ultramarathon running and upper respiratory tract infections. An epidemiological survey. S Afr Med J 64: 582-584, 1983.
15. Shepard R. J., Shek P. N.: Athletic competition and susceptibility to infection. Clin J Sports Med 3: 75-77, 1993.
16. Tomasi T. B., Trudeau F. B., Czerwinski C., Erredge S.: Immune parameters in athletes before and after strenuous exercise. J Clin Immunol 2: 173-178, 1982.